Company Number: 13579964

Analysis Date: 2025-07-29 19:36 UTC

Financial Health Assessment for ENTORT LTD

---

1. Financial Health Score: B

Explanation:
ENTORT LTD demonstrates a solid and improving financial position with strong working capital and growing equity, indicative of a healthy financial "pulse." The company is in the micro-entity category, operating in a specialized medical practice sector, with consistent asset growth and manageable liabilities. However, some caution is warranted due to director advances and reliance on a single controlling stakeholder, which introduces potential governance and liquidity risks.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Fixed Assets	20,948	Modest investment in long-term resources, slight growth.
Current Assets	353,926	Healthy cash and receivables supporting short-term needs.
Current Liabilities	91,193	Debts due within a year, manageable relative to assets.
Net Current Assets (Working Capital)	262,733	Strong positive working capital, "healthy cash flow".
Total Assets Less Current Liabilities	283,681	Indicates net resources after short-term obligations.
Shareholders’ Funds (Equity)	283,681	Company’s net worth, growing steadily over 4 years.
Director’s Advances	30,129	Significant loan to the company from director, watch carefully.

• Working Capital is strong and improving, showing the company can comfortably meet short-term obligations.
• Equity growth from £87k in 2021 to £283k in 2024 signals profitability or capital injections.
• Director’s loan account indicates an ongoing financial relationship; this could be a symptom of cash flow management strategies or funding gaps.
• The company has no overdue filings, indicating good compliance and governance.

---

3. Diagnosis: Financial Condition Overview

The financial "vital signs" of ENTORT LTD reveal a company in good health. The rising net assets and strong working capital suggest it is effectively managing its liquidity and capital structure. The increase in fixed assets shows some reinvestment into the business, supporting future operations.

The presence of a director’s loan (advances) of over £30k is a notable symptom. While not uncommon in small private companies, it reflects reliance on internal funding which may mask underlying cash flow constraints or investment needs. The company should monitor this closely to avoid potential "financial distress."

ENTORT LTD is under the sole control of Prof. Anthony Wright, who holds full ownership and voting rights. This concentrated control can be efficient but also poses governance risks if alternative viewpoints or oversight are limited.

Overall, the company’s financial "heartbeat" is steady, with no immediate signs of distress such as excessive liabilities or negative working capital.

---

4. Recommendations: Steps to Strengthen Financial Wellness

• Monitor Director Advances: Regularly review the director’s loan account. Consider formalising repayment plans or converting advances into equity to reduce dependency on director funding.
• Maintain Working Capital Discipline: Continue to manage receivables, payables, and cash reserves prudently to sustain healthy liquidity.
• Plan for Asset Growth: Evaluate the return on fixed asset investments to ensure they contribute to income growth without straining cash flow.
• Consider Governance Enhancements: Explore appointing additional directors or a financial advisor to broaden oversight and reduce concentration risk.
• Prepare for Future Compliance: Keep on schedule with filings to avoid penalties, and consider preparing for audit thresholds if the company grows beyond micro-entity limits.
• Scenario Planning: Run cash flow forecasts to preempt any liquidity crunch, especially if business expansion or unexpected expenses arise.

---